ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

April 13, 2020

Primary Completion Date

July 20, 2020

Study Completion Date

July 20, 2020

Conditions
COVID-19
Interventions
DRUG

Hydroxychloroquine

COVID19

Trial Locations (2)

T2N 2T9

University of Calgary/Foothills Medical Centre, Calgary

Unknown

University of Alberta, Edmonton

All Listed Sponsors
collaborator

Alberta Health services

OTHER

collaborator

University of Alberta

OTHER

collaborator

University of Calgary

OTHER

collaborator

Calgary Health Trust

OTHER

collaborator

Alberta Innovates Health Solutions

OTHER

collaborator

Government of Alberta

OTHER_GOV

lead

Dr. Michael Hill

OTHER